SSWM
SUPN icon

Sheets Smith Wealth Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Sheets Smith Wealth Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,671
Closed -$347K – 331
2017
Q3 		$347K Sell
8,671
-88
-1% -$3.81K 0.09% 226
2017
Q2 		$378K Buy
+8,759
New +$312K 0.1% 197
2017
Q1 		– Sell
-36,158
Closed -$913K – 304
2016
Q4 		$913K Sell
36,158
-1,908
-5% -$42.6K 0.26% 107
2016
Q3 		$941K Buy
+38,066
New +$862K 0.27% 105

Other funds holding SUPN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return